1. Home
  2. BTMD

as 03-25-2025 11:31am EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations.

Founded: 2012 Country:
United States
United States
Employees: N/A City: IRVING
Market Cap: 136.0M IPO Year: N/A
Target Price: $8.00 AVG Volume (30 days): 307.7K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 0.09 EPS Growth: -30.22
52 Week Low/High: $3.04 - $8.44 Next Earning Date: 03-12-2025
Revenue: $197,191,000 Revenue Growth: 6.38%
Revenue Growth (this year): 17.51% Revenue Growth (next year): 15.84%

BTMD Daily Stock ML Predictions

Stock Insider Trading Activity of Biote Corp. (BTMD)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
HEYER ANDREW R BTMD Director Mar 17 '25 Buy $3.95 75,000 $296,042.50 370,201
Cone Stephen Mark BTMD Director Mar 17 '25 Buy $3.88 38,104 $147,843.52 160,829
Christensen Bret BTMD Chief Executive Officer Mar 17 '25 Buy $3.87 37,595 $145,492.65 37,595
Guines LLC BTMD 10% Owner Mar 13 '25 Buy $3.48 856,609 $2,784,419.26 3,820,938

Share on Social Networks: